Distinguished as a billionaire investor and the visionary founder of Bridgewater Associates, Ray Dalio has prominently demonstrated a keen affinity for healthcare investments. His discerning focus extends to the realms of biotechnology and cutting-edge medical research. Notably, his strategic investments have been channeled into noteworthy biotechnology enterprises like NovoCure Limited, underscoring his commitment to fostering advancements at the forefront of medical innovation.